Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
Scheinberg
Adam
A
O'Flaherty
Stephen
S
Waugh
Mary-Clare
MC
Baxter
Alexandra
A
Gurd
Kristy
K
D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A